These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30115659)

  • 1. A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation.
    Kauskot A; Pascreau T; Adam F; Bruneel A; Reperant C; Lourenco-Rodrigues MD; Rosa JP; Petermann R; Maurey H; Auditeau C; Lasne D; Denis CV; Bryckaert M; de Lonlay P; Lavenu-Bombled C; Melki J; Borgel D
    Haematologica; 2018 Dec; 103(12):e613-e617. PubMed ID: 30115659
    [No Abstract]   [Full Text] [Related]  

  • 2. Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver.
    Ma X; Li Y; Kondo Y; Shi H; Han J; Jiang Y; Bai X; Archer-Hartmann SA; Azadi P; Ruan C; Fu J; Xia L
    Haematologica; 2021 Mar; 106(3):759-769. PubMed ID: 32303557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual disability and bleeding diathesis due to deficient CMP--sialic acid transport.
    Mohamed M; Ashikov A; Guillard M; Robben JH; Schmidt S; van den Heuvel B; de Brouwer AP; Gerardy-Schahn R; Deen PM; Wevers RA; Lefeber DJ; Morava E
    Neurology; 2013 Aug; 81(7):681-7. PubMed ID: 23873973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.
    Di Buduo CA; Alberelli MA; Glembostky AC; Podda G; Lev PR; Cattaneo M; Landolfi R; Heller PG; Balduini A; De Candia E
    Sci Rep; 2016 Mar; 6():23213. PubMed ID: 26987485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet formation.
    Thon JN; Italiano JE
    Semin Hematol; 2010 Jul; 47(3):220-6. PubMed ID: 20620432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.
    Riemersma M; Sandrock J; Boltje TJ; Büll C; Heise T; Ashikov A; Adema GJ; van Bokhoven H; Lefeber DJ
    Hum Mol Genet; 2015 Apr; 24(8):2241-6. PubMed ID: 25552652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism.
    Avanzi MP; Izak M; Oluwadara OE; Mitchell WB
    PLoS One; 2015; 10(4):e0125057. PubMed ID: 25875470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.
    Ng BG; Asteggiano CG; Kircher M; Buckingham KJ; Raymond K; Nickerson DA; Shendure J; Bamshad MJ; ; Ensslen M; Freeze HH
    Am J Med Genet A; 2017 Nov; 173(11):2906-2911. PubMed ID: 28856833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Insights into Selected Disease-Causing Mutations within the
    Szulc B; Zadorozhna Y; Olczak M; Wiertelak W; Maszczak-Seneczko D
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule polyglutamylation and acetylation drive microtubule dynamics critical for platelet formation.
    van Dijk J; Bompard G; Cau J; Kunishima S; Rabeharivelo G; Mateos-Langerak J; Cazevieille C; Cavelier P; Boizet-Bonhoure B; Delsert C; Morin N
    BMC Biol; 2018 Oct; 16(1):116. PubMed ID: 30336771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of platelet proteins during maturation of human megakaryocytes and of the K 562/HEL cell lines.
    Vainchenker W; Kieffer N; Cramer E; Vinci G; Debili N; Henri A; Titeux M; Guichard J; Mishal Z; Breton-Gorius J
    Prog Clin Biol Res; 1986; 215():227-40. PubMed ID: 2941767
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
    Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
    Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proplatelet formation in megakaryocytes is associated with endoplasmic reticulum stress.
    Morishima N; Nakanishi K
    Genes Cells; 2016 Jul; 21(7):798-806. PubMed ID: 27296088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for genetic modification of megakaryocytes and platelets.
    Pendaries C; Watson SP; Spalton JC
    Platelets; 2007 Sep; 18(6):393-408. PubMed ID: 17763148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts.
    Hohmann S; Schweinfurth N; Lau T; Deuschle M; Lederbogen F; Banaschewski T; Schloss P
    Cell Tissue Res; 2011 Nov; 346(2):151-61. PubMed ID: 22006250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2.
    Li D; Mukhopadhyay S
    J Biol Chem; 2021 Sep; 297(3):101069. PubMed ID: 34384782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic processes in megakaryocytes and platelets.
    White MJ; Kile BT
    Semin Hematol; 2010 Jul; 47(3):227-34. PubMed ID: 20620433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeing is believing: use of advanced imaging to study platelets and megakaryocytes.
    Thomas SG; Poulter NS
    Platelets; 2020 Jul; 31(5):549-550. PubMed ID: 32427510
    [No Abstract]   [Full Text] [Related]  

  • 20. Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4.
    Golfier S; Kondo S; Schulze T; Takeuchi T; Vassileva G; Achtman AH; Gräler MH; Abbondanzo SJ; Wiekowski M; Kremmer E; Endo Y; Lira SA; Bacon KB; Lipp M
    FASEB J; 2010 Dec; 24(12):4701-10. PubMed ID: 20686109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.